Filing Details

Accession Number:
0001104659-23-032313
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-14 16:34:40
Reporting Period:
2023-03-10
Accepted Time:
2023-03-14 16:34:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1504776 Warby Parker Inc. WRBY Ophthalmic Goods (3851) 800423634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1883325 Clive Steven Miller C/O Warby Parker Inc.,
233 Spring Street, 6Th Floor East
New York NY 10013
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2023-03-10 14,251 $0.00 179,798 No 4 M Direct
Class A Common Stock Disposition 2023-03-10 6,000 $11.04 173,798 No 4 S Direct
Class A Common Stock Disposition 2023-03-13 8,251 $10.89 165,547 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Restricted Stock Units Disposition 2023-03-10 1,981 $0.00 1,981 $0.00
Class A Common Stock Restricted Stock Units Disposition 2023-03-10 2,525 $0.00 2,525 $0.00
Class A Common Stock Restricted Stock Units Disposition 2023-03-10 1,690 $0.00 1,690 $0.00
Class A Common Stock Restricted Stock Units Disposition 2023-03-10 5,096 $0.00 5,096 $0.00
Class A Common Stock Restricted Stock Units Disposition 2023-03-10 2,959 $0.00 2,959 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,188 No 4 M Direct
9,259 No 4 M Direct
0 No 4 M Direct
49,260 No 4 M Direct
139,116 No 4 M Direct
Footnotes
  1. These share sales are required by the Issuer's equity compensation plan to cover taxes due on restricted stock units ("RSUs") that vested.
  2. The sales reported were effected pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.48 to $11.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. Each RSU represents a contingent right to receive one share of the Company's Class A Common Stock.
  5. This filing relates to the occurrence of a RSU vesting event.
  6. The RSUs will vest in 48 monthly installments beginning on January 1, 2021.
  7. The RSUs will vest in 48 monthly installments beginning on January 1, 2020.
  8. The RSUs will vest in 48 monthly installments beginning on January 1, 2019.
  9. The RSUs will vest in 48 monthly installments beginning on July 1, 2021.
  10. The RSUs will vest in 48 substantially equal monthly installments beginning on February 3, 2023.